Physics of pure and non-pure positron emitters for PET: a review and a discussion

With the increased interest in new PET tracers, gene-targeted therapy, immunoPET, and theranostics, other radioisotopes will be increasingly used in clinical PET scanners, in addition to 18F. Some of the most interesting radioisotopes with prospective use in the new fields are not pure short-range β+ emitters but can be associated with gamma emissions in coincidence with the annihilation radiation (prompt gamma), gamma-gamma cascades, intense Bremsstrahlung radiation, high-energy positrons that may escape out of the patient skin, and high-energy gamma rays that result in some e+/e− pair production. The high level of sophistication in data correction and excellent quantitative accuracy that has been reached for 18F in recent years can be questioned by these effects. In this work, we review the physics and the scientific literature and evaluate the effect of these additional phenomena on the PET data for each of a series of radioisotopes: 11C, 13N, 15O, 18F, 64Cu, 68Ga, 76Br, 82Rb, 86Y, 89Zr, 90Y, and 124I. In particular, we discuss the present complications arising from the prompt gammas, and we review the scientific literature on prompt gamma correction. For some of the radioisotopes considered in this work, prompt gamma correction is definitely needed to assure acceptable image quality, and several approaches have been proposed in recent years. Bremsstrahlung photons and 176Lu background were also evaluated.

[1]  L A DeWerd,et al.  A new internal pair production branching ratio of 90Y: the development of a non-destructive assay for 90Y and 90Sr. , 2007, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[2]  H. Herzog,et al.  PET imaging with yttrium-86: comparison of phantom measurements acquired with different PET scanners before and after applying background subtraction , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[3]  D. Townsend,et al.  Beyond 18F-FDG: Characterization of PET/CT and PET/MR Scanners for a Comprehensive Set of Positron Emitters of Growing Application—18F, 11C, 89Zr, 124I, 68Ga, and 90Y , 2015, The Journal of Nuclear Medicine.

[4]  Richard Laforest,et al.  Quantitative small animal PET imaging with nonconventional nuclides. , 2009, Nuclear medicine and biology.

[5]  M. Zalutsky Potential of Immuno–Positron Emission Tomography for Tumor Imaging and Immunotherapy Planning , 2006, Clinical Cancer Research.

[6]  G. Glatting,et al.  Quantitative imaging of yttrium-86 PET with the ECAT EXACT HR+ in 2D mode. , 2004, Cancer biotherapy & radiopharmaceuticals.

[7]  U. Pietrzyk,et al.  Using Monte-Carlo simulations to implement corrections for I-124 as a non-pure positron emitter in small animal and human PET imaging , 2011, 2011 IEEE Nuclear Science Symposium Conference Record.

[8]  I. Velikyan Prospective of 68Ga-Radiopharmaceutical Development , 2013, Theranostics.

[9]  Maurizio Conti,et al.  (90)Y -PET imaging: Exploring limitations and accuracy under conditions of low counts and high random fraction. , 2015, Medical physics.

[10]  C. C. Watson,et al.  New, faster, image-based scatter correction for 3D PET , 1999, 1999 IEEE Nuclear Science Symposium. Conference Record. 1999 Nuclear Science Symposium and Medical Imaging Conference (Cat. No.99CH37019).

[11]  A Celler,et al.  Dual-isotope PET using positron-gamma emitters , 2011, Physics in medicine and biology.

[12]  A. Bockisch Matched pairs for radionuclide-based imaging and therapy , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[13]  C Le Loirec,et al.  Positron range in PET imaging: non-conventional isotopes , 2014, Physics in medicine and biology.

[14]  C. Bodet-Milin,et al.  Assessment of acquisition protocols for routine imaging of Y-90 using PET/CT , 2013, EJNMMI Research.

[15]  M. Lubberink,et al.  Performance of coincidence imaging with long-lived positron emitters as an alternative to dedicated PET and SPECT , 2004, Physics in medicine and biology.

[16]  M. Lubberink,et al.  Quantitative imaging and correction for cascade gamma radiation of 76Br with 2D and 3D PET. , 2002, Physics in medicine and biology.

[17]  Bradley J Beattie,et al.  Quantitative imaging of bromine-76 and yttrium-86 with PET: a method for the removal of spurious activity introduced by cascade gamma rays. , 2003, Medical physics.

[18]  S. Nekolla,et al.  Prompt Gamma Correction for Ga-68 PSMA PET studies , 2015, 2015 IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC).

[19]  L. V. Elmbt,et al.  Feasibility of 90Y TOF PET-based dosimetry in liver metastasis therapy using SIR-Spheres , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[20]  S. Vallabhajosula,et al.  A broad overview of positron emission tomography radiopharmaceuticals and clinical applications: what is new? , 2011, Seminars in nuclear medicine.

[21]  Larson,et al.  Quantitative Imaging of Yttrium-86 with PET. The Occurrence and Correction of Anomalous Apparent Activity in High Density Regions. , 2000, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.

[22]  G. V. van Dongen,et al.  Immuno-PET: a navigator in monoclonal antibody development and applications. , 2007, The oncologist.

[23]  Janice M Reichert,et al.  Monoclonal antibodies as innovative therapeutics. , 2008, Current pharmaceutical biotechnology.

[24]  G. Teule,et al.  Identification of a Shine-Through Artifact in the Trachea with 124I PET/CT , 2009, Journal of Nuclear Medicine.

[25]  Stephen E. Derenzo,et al.  Mathematical Removal of Positron Range Blurring in High Resolution Tomography , 1986, IEEE Transactions on Nuclear Science.

[26]  G. V. van Dongen,et al.  The promise of immuno-PET in radioimmunotherapy. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  Kathy Willowson,et al.  Quantitative and Qualitative Assessment of Yttrium-90 PET/CT Imaging , 2014, PloS one.

[28]  S. Walrand,et al.  Quantitation in PET using isotopes emitting prompt single gammas: application to yttrium-86 , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[29]  R Laforest,et al.  Image quality with non-standard nuclides in PET. , 2008, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[30]  G. El Fakhri,et al.  Monte Carlo modeling of cascade gamma rays in 86Y PET imaging: preliminary results , 2009, Physics in medicine and biology.

[31]  E. Hoffman,et al.  Calculation of positron range and its effect on the fundamental limit of positron emission tomography system spatial resolution. , 1999, Physics in medicine and biology.

[32]  Michael Tapner,et al.  A multicentre comparison of quantitative 90Y PET/CT for dosimetric purposes after radioembolization with resin microspheres , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[33]  Dan J. Kadrmas,et al.  Methodology for Quantitative Rapid Multi-Tracer PET Tumor Characterizations , 2013, Theranostics.

[34]  C. L. Loirec,et al.  Positron range in PET imaging: an alternative approach for assessing and correcting the blurring , 2012, Physics in medicine and biology.

[35]  Guy Bormans,et al.  PET Imaging of Macrophage Mannose Receptor–Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments , 2015, The Journal of Nuclear Medicine.

[36]  U. Pietrzyk,et al.  Implementation of Cascade Gamma and Positron Range Corrections for I-124 Small Animal PET , 2014, IEEE Transactions on Nuclear Science.

[37]  A. Celler,et al.  Dual-radioisotope PET data acquisition and analysis , 2011, 2011 IEEE Nuclear Science Symposium Conference Record.

[38]  S. Vandenberghe,et al.  Comparison of yttrium-90 quantitative imaging by TOF and non-TOF PET in a phantom of liver selective internal radiotherapy , 2011, Physics in medicine and biology.

[39]  M. Papisov,et al.  Iodine-124 as a label for pharmacological PET imaging. , 2009, Molecular pharmaceutics.

[40]  J. Bading,et al.  Imaging of Cell Proliferation: Status and Prospects , 2008, Journal of Nuclear Medicine.

[41]  J. Humm,et al.  PET Imaging of 86Y-Labeled Anti-Lewis Y Monoclonal Antibodies in a Nude Mouse Model: Comparison Between 86Y and 111In Radiolabels , 2001 .

[42]  Magdalena Rafecas,et al.  Shine-Through in PET/MR Imaging: Effects of the Magnetic Field on Positron Range and Subsequent Image Artifacts , 2015, The Journal of Nuclear Medicine.

[43]  M. Partridge,et al.  Optimization and assessment of quantitative 124I imaging on a Philips Gemini dual GS PET/CT system , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[44]  A. Buck,et al.  Is the Image Quality of I-124-PET Impaired by an Automatic Correction of Prompt Gammas? , 2013, PloS one.

[45]  Charles C. Watson,et al.  Prompt gamma correction for improved quantification in 82Rb PET , 2008 .

[46]  J. M. Udias,et al.  Simulation of triple coincidences in PET , 2013, 2013 IEEE Nuclear Science Symposium and Medical Imaging Conference (2013 NSS/MIC).

[47]  Martin Gotthardt,et al.  Image-Quality Assessment for Several Positron Emitters Using the NEMA NU 4-2008 Standards in the Siemens Inveon Small-Animal PET Scanner , 2010, Journal of Nuclear Medicine.

[48]  S. Surti,et al.  Correction Technique for Cascade Gammas in I-124 Imaging on a Fully-3D, Time-of-Flight PET Scanner , 2009, IEEE Transactions on Nuclear Science.

[49]  Habib Zaidi,et al.  Isotope specific resolution recovery image reconstruction in high resolution PET imaging. , 2014, Medical physics.